Good Sense Hemorrhoid Products Recalled for Improper Storage Conditions
Good Sense Hemorrhoid Ointment and Wipes sold at Family Dollar stores from April through June 2022 are being recalled due to storage outside appropriate temperature conditions. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard—improper storage conditions—is a manufacturing deviation that poses low risk to consumers of a topical drug. This is a precautionary recall to ensure product quality standards.
Plain-English summary
Good Sense Hemorrhoid Ointment (2 oz, SKU 910325) and Good Sense Hemorrhoidal Wipes (48 count, SKU 902260) distributed to specific Family Dollar Store locations between April 30, 2022 and June 10, 2022 are being recalled.
The products were recalled because they were held outside of appropriate storage temperature conditions. This represents a deviation from Good Manufacturing Practice (CGMP) standards.
No illnesses or injuries related to these products have been reported to date.
The recalled product
- Product
- GOOD SENSE HEMORRHOID OINTMENT 2 OZ SKU 910325 GOOD SENSE HEMORRHOIDAL WIPES 48 CT SKU 902260 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 910325
- 902260
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27